ProteoChip-based immunoassay method for quantitative determination of serum tumor markers

Biochip Journal

Volumn 3, Issue 2, 2009, Pages 171-180

  Jang, Hye Jee ^a   Cho, Yong Wan ^a   Lee, Eun Kyoung ^a   Lee, Yoonsuk ^a   Park, Il Jun ^a   Park, Young Nam ^b   Lee, Chang Woo ^b   Kang, In Cheol ^c   Han, Moon Hi ^a  

^a Proteogen Inc   (South Korea)

^b YongDong Diagnostics   (South Korea)

^c Hoseo University   (South Korea)

Author keywords

ELISA; ProteoChip; Tumor markers; Well on a chip

Indexed keywords

EID: 70449095567     PISSN: 19760280     EISSN: 20927843     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Zhu, H. et al. Global analysis of protein activities using proteome chips. Science 293, 2101-2105 (2001).
2. Kingsmore, S.F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5, 310-320 (2006).
3. Michaud, G.A. et al. Analyzing antibody specificity with whole proteome microarrays Schweitzer. Nat. Biotechnol. 21, 1509-1512 (2003).
4. Templin, M.F. et al. Protein microarray technology. Trends Biotechnol. 20, 160-166 (2002).
5. Uttamchandani, M., Walsh, D.P., Yao, S.Q. & Chang, Y.T. Small molecule microarrays: recent advances and applications. Curr. Opin. Chem. Biol. 9, 4-13 (2005).
6. Kusnezow, W. & Hoheisel, J.D. Solid supports for microarray immunoassays. J. Mol. Recognit. 16, 165-176 (2003).
7. Seong, S.Y. & Choi, C.Y. Current status of protein chip development in terms of fabrication and application. Proteomics 3, 2176-2189 (2003).
8. Kodadek, T. Protein microarrays: prospects and problems. Chem. Biol. 8, 105-115 (2001).
9. Gutsche, C.D. Calixarenes revisited, Royal Society of Chemistry: Cambridge, UK.(1998).
10. Oh, S.W. et al. Calixarene derivative as a tool for highly sensitive detection and oriented immobilization of proteins in a microarray format through noncovalent molecular interaction. The FASEB Journal 19, 1335-1337 (2005).
11. Lee, Y. et al. ProteoChip: a highly sensitive protein microarray prepared by a novel method of protein immobilization for application of protein-protein interaction studies. Proteomics 3, 2289-2304 (2003).
12. Park, J.Y., Kim, B.C. & Park, S.M. Molecular recognition of protonated polyamines at calix[4]crown-5 self-assembled monolayer modified electrodes by impedance measurements. Anal. Chem. 79, 1890-1896 (2007).
13. Ahn, E.H. et al. Profiling of differential protein expression in angiogenin-induced HUVECs using antibody-arrayed ProteoChip. Proteomics 6, 1104-1109 (2006).
14. Sasakura, Y., Kanda, K. & Fukuzono, S. Microarray techniques for more rapid protein quantification: use of single spot multiplex analysis and a vibration reaction unit. Anal. Chim. Acta. 564, 53-58 (2006).
15. Lee, Y., Kang, D.K., Chang, S.I., Han, M.H. & Kang, I.C. High-throughput screening of novel peptide inhibitors of an integrin receptor from the hexapeptide library by using a protein microarray chip. J. Biomol. Screen. 9, 687-694 (2004).
16. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y.Y. & Chan, D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48, 1296-1304 (2002).
17. Zhong, L. et al. Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am. J. Respir. Crit. Care Med. 172, 1308-1314 (2005).
18. Sanchez-Carbayo, M. Antibody arrays: technical considerations and clinical applications in cancer. Clin. Chem. 52, 1651-1659 (2006).
19. Combaret, V. et al. Protein chip array profiling analysis of sera from neuroblastoma patients. Cancer Lett. 228, 91-96 (2005).
20. Askari, M.D., Miller, G.H. & Vo-Dinh, T. Simultaneous detection of the tumor suppressor FHIT gene and protein using the multi-functional biochip. Cancer Detect Prev. 26, 331-342 (2002).
21. Chen, S.P. et al. Comparison of sensitivity and specificity in three commercial foot-and-mouth disease virus non-structural protein ELISA kits with swine sera in Taiwan. Vet. Microbiol. 119, 164-172 (2007).
22. U.S. Food and Drug Administration. Center for Drug Evaluation and Research. http://www.fda.gov/CDER/guidance/4252fnl.htm(Accessed May 2001).
23. Tam, S.W., Wiese, R., Lee, S., Gilmore, J. & Kumble, K.D. Simultaneous analysis of eight human Th1/Th2 cytokines using microarrays. J. Immunol. Methods 261, 157-165 (2002).
24. Du, H., Yang, W., Xing, W., Su, Y. & Cheng, J. Parallel detection and quantification using nine immunoassays in a protein microarray for drug from serum samples. Biomed. Microdevices 7, 143-146 (2005).
25. Sasakura, Y. et al. Protein microarray system for detecting protein-protein interactions using an anti-His-tag antibody and fluorescence scanning: effects of the heme redox state on protein-protein interactions of heme-regulated phosphodiesterase from Escherichia coli. Anal. Chem. 76, 6521-6527 (2004).
26. Miller, J.C. et al. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 3, 56-63 (2003).
27. Zajac, A., Song, D., Qian, W. & Zhukov, T. Protein microarrays and quantum dot probes for early cancer detection. Colloids. Surf. B Biointerfaces 58, 309-314 (2007).
28. Martin, A.V., Colomer, R. & Menendez, J.A. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer. Euro. J. Cancer 43, 1117-1124 (2007).
29. Glökler, J. & Angenendt, P. Protein and antibody microarray technology. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 797, 229-240 (2003).
30. Pawlak, M. et al. Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics 2, 383-393 (2002).
31. Granger, J., Siddiqui, J., Copeland, S. & Remick, D. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 5, 4713-4718 (2005).
32. Stamey, T.A. Lower limits of detection, biological detection limits, functional sensitivity, or residual cancer detection limit? Sensitivity reports on prostate-specific antigen assays mislead clinicians. Clin. Chem. 42, 849-852 (1996).
33. NCCLS Document EP17-P, Protocols for demonstration, verification, and evaluation of limits of detection and quantitation, Proposed document under development, National Committee for Clinical Laboratory Standards, Wayne, PA.
34. International Conference on Harmonization (ICH), Guidance for Industry, Q2B Validation for Analytical Procedures: Methodology, November, 1996.